Karande SP, Munshi RP, Kumbhar DA. A double blind, randomized, placebo controlled, phase IV, proof-of-concept, comparative study to evaluate the efficacy and safety of Swasawin asthaloc tablets when given as add-on therapy in patients suffering from mild to moderate persistent bronchial asthma. Int J Res Med Sci [Internet]. 2017 Oct. 27 [cited 2025 Oct. 12];5(11):4929-36. Available from: https://www.msjonline.org/index.php/ijrms/article/view/3977